结肠癌伴肝转移行同期手术切除42例临床观察  

Synchronous Resection for 42 Cases of Colonic Carcinoma Accompanied with Liver Metastasis：Clinical Observation

作　　者：白景珍[1] 张建生[1] 吴会国[1] 韩恩崑[1] 

机构地区：[1]天津医科大学宝坻临床学院胃肠外科,天津301800

出　　处：《中国肛肠病杂志》2011年第5期39-40,共2页Chinese Journal of Coloproctology

摘　　要：为探讨对结肠癌伴肝转移患者行同期手术切除结肠原发病灶及肝转移灶的安全性及疗效，回顾42例结肠癌伴肝转移病人行同期切除的临床资料，对手术适应症、手术方式以及随访结果进行讨论。结果显示，行结肠癌及肝转移灶同期切除42例，术后1，2，3年生存率分别为73．8％，61．9％和35．7％，中位生存期为26．8个月。并发症发生率为16．7％（7／42），围手术期病死率为2．3％（1／42）。结果表明，结肠癌伴肝转移行同期手术切除是安仝可靠的，可明显延长患者的生存时间。The objective of this study was to explore the safety and therapeutic effect of synchronous resecring colonic primary lesion and liver metastasis lesion of patients with colonic carcinoma associated with liver metastasis. Authors retrospectively analysed the clinical data from the 42 patients who had received the synchronous resection procedure, and discussed operative indication, procedure mode and follow up outcome. As results, in the 42 cases after operation the survival rate of 1,2,3 year was 73. 8%,61. 9%, 35.7% ,respectively;median survival duration was 26.8 months;the incidence of complication was 16.7% （7/42）,the perioperativc death rate was 2.3% （1/42）. These results show that above-mentioned synchro nous resection is safe and feasible,and can significantly lengthen the survival duration.

关 键 词：结肠癌 肝转移 手术切除 

分 类 号：R735.3[医药卫生—肿瘤]